Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

pure nanodrug of 5, 10, 15, 20-tetra(4-pyridyl) porphyrin) and teniposide

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

5,10,15,20-tetrakis-(4-pyridyl)-21H,23H-porphine

5,10,15,20-tetra(4-pyridyl)-21H,23H-porphyrin 5,10,15,20-tetra-(4-pyridyl)-porphyrin 5,10,15,20-tetra(4-pyridyl)porphyrin meso-tetra(4-pyridyl)porphyrin meso-tetra-4-pyridyl-porphine tetrakis(4-pyridyl)porphyrin H2P(pPyr)4 H2TPyP HTPyP TPyP MTP
Type Single Compound
Formula C40H26N8
Role raw materials
2

teniposide

VM-26
Type Single Compound
Formula C32H32O13S
Role raw materials

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
scanning electron microscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 5,10,15,20-tetrakis-(4-pyridyl)-21H,23H-porphine
  • teniposide
  1. v9mbuB0dtePEG9Gr9pFFUhACwlFr6tHNBVcx2jCuJV
Product

pure nanodrug of 5, 10, 15, 20-tetra(4-pyridyl) porphyrin) and teniposide

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial